Drug agency to screen product monograph prior to marketing

Published: 2011-12-05 06:58:00

Updated: 2011-12-05 06:58:00

The Korea Food and Drug Administration has recently unveiled its plan to screen the contents of a drug’s insert paper which include product summary, pharmacological action and active ingredients prior to its launching to thoroughly assure drug safety in use.

The government plans to adopt the m...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK